Skip to content

Clinical trials

Completed Mucopolysaccharidosis III trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis III Status: Completed Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20102
20123
20131
20142
20152
20161
20181
20191
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire3
Alexion Pharmaceuticals, Inc.2
Allievex Corporation2
Masonic Cancer Center, University of Minnesota2
Swedish Orphan Biovitrum2
University of Minnesota2
Lynda E Polgreen1
Nationwide Children's Hospital1
Phoenix Nest1
Sanguine Biosciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis III18
Mucopolysaccharidoses5
Leukodystrophy, Globoid Cell3
Lysosomal Storage Diseases3
Adrenoleukodystrophy2
Gangliosidosis, GM12
Leukodystrophy, Metachromatic2
Metabolism, Inborn Errors2
Mucolipidoses2
Mucopolysaccharidosis I2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.